BIOA
BioAge Labs (BIOA)
$32
About BioAge Labs (BIOA)
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.
Details
Daily high
$22.45
Daily low
$20.61
Price at open
$20.90
52 Week High
$24.00
52 Week Low
$4.06
Market cap
954.4M
Dividend yield
0.00%
Volume
498,063
Avg. volume
471,320
P/E ratio
-8.92
BioAge Labs News
Details
Daily high
$22.45
Daily low
$20.61
Price at open
$20.90
52 Week High
$24.00
52 Week Low
$4.06
Market cap
954.4M
Dividend yield
0.00%
Volume
498,063
Avg. volume
471,320
P/E ratio
-8.92